Volume 41 · Number 3
MARCH 2011
Underutilized Treatments in Depression and Anxiety
Psychiatr Ann. 2011 March;41(3):138-140
By Bezalel Dantz, MD
An issue of Psychiatric Annals devoted to generics? In an era when yesterday’s racemate is replaced by today’s left-handed isomer, it is rare to find coverage of medications that have no sponsor. The idea for Underutilized Treatments germinated from years of supervising psychiatry residents in their outpatient clinics at Rush University Medical Center in Chicago. Their quizzical looks at the mention of tricyclics or monoamine oxidase inhibitors (MAOIs), in contrast to their confidence in prescribing the (arguably more toxic) atypical antipsychotics, serve as an inspiration for this theme issue.
Underutilized Treatments in Depression and Anxiety
Outlier Medications: They Can Help Our Patients
Jan Fawcett, MD
A 21-year-old Woman with Bipolar Disorder
Ghulam-Murtaza Bajwa, MD;
Deepa Hasija, MD;
Sree Latha Krishna Jadapalle, MD;
Amel Badr, MD
Trazodone: The Forgotten Antidepressant
Benjamin Raatjes, MD;
Bezalel Dantz, MD
The Tricyclics: More than Just Antidepressants
Aaron Plattner, MD;
Bezalel Dantz, MD
Buspirone: Anxiolytic, Antidepressant, or Neither?
John F. Egger, MD;
Charles Hebert, MD
The Monoamine Oxidase Inhibitors: Relics Reconsidered
Virginia O'Brien, MD
Nefazodone Revisited
Bezalel Dantz, MD
